The opportunities and challenges of perioperative therapy of localized non-small cell lung cancer—thoughts from the KEYNOTE-671 trial

Nathaniel Deboever, Jianjun Zhang · 2023

Read The opportunities and challenges of perioperative therapy of localized non-small cell lung cancer—thoughts from the KEYNOTE-671 trial by Nathaniel Deboever, Jianjun Zhang (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10713268.txt.

Description

A peer-reviewed research article from Europe PMC (2023). Results from the phase II trial (NADIM II) evaluating the effect of perioperative nivolumab and chemotherapy have demonstrated significantly increased pathological complete response (pCR) in patients who received combination therapy compared to chemotherapy alone (5).

Catalog record

CREATORNathaniel Deboever, Jianjun Zhang
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE15 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10713268

Browse the full library · About the Tower of Babel